by: Reed Parker, Inside INdiana Business
Posted: Apr 27, 2021 / 10:22 AM EST / Updated: April 27, 2021 / 11:00 AM EST
INDIANAPOLIS (Inside INdiana Business) – The state of Indiana has reached a multi-million dollar settlement with a pharmaceutical distributor for the opioid restoration drug Suboxone. Indiana Attorney General Todd Rokita says the state will receive $ 4.3 million after Indivior failed to properly market and sell Suboxone.
Rokita says six whistleblower lawsuits deny Indivior’s statements and marketing tactics related to the drug have resulted in inappropriately spending Medicaid funds.
According to Rokita’s office, from 2010 to 215, Indiana and other states claimed Indivior promoted Suboxone to doctors who write prescriptions for the wrong reasons. claimed a newer form of the drug that dissolves under the tongue was less likely to be abused; and filed false claims with the US Food and Drug Administration to delay generic competition for Suboxone in the market and control the price of the drug, including Medicaid programs.
“Indivior’s actions harmed potentially vulnerable Hoosiers and helped maintain drug addiction in this country when they claimed to be exterminating it. Worse still, they used ill-received Medicaid funds to divert resources away from a program designed to help provide legitimate medical care to low-income patients who really need it, “Rokita said.
Rokita said Indivior will pay $ 300 million to solve civil fraud allegations, of which more than $ 203 million will go to Medicaid. In 2020, several Indivior officials were convicted of crimes related to the marketing of Suboxone.